Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-19 Purchase | 2021-11-19 8:36 pm | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr. VP, Chief Medical Officer | 10,000 | $2.56 | $25,600 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-05 Option Award | 2024-02-07 5:45 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr VP & Chief Medical Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 7:50 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr. VP, Chief Medical Officer | 300,000 | $0 | 310,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:16 pm | N/A 2032-01-17 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr. VP, Chief Medical Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2021-08-19 Option Award | 2021-08-23 4:53 pm | N/A 2031-08-19 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr. VP, Chief Medical Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:45 pm | N/A 2031-01-04 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr. VP, Chief Medical Officer | 343,000 | $0 | 343,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-03 9:36 pm | N/A 2030-01-30 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr. VP, Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 4:00 pm | N/A 2030-12-31 | Aptose Biosciences Inc. | APTO | Bejar Rafael Chief Medical Officer | 400,000 | $0 | 0 (Direct) | View |